Sieverink, C.A.; Batista, R.P.M.; Prazeres, H.J.M.; Vinagre, J.; Sampaio, C.; Leão, R.R.; Máximo, V.; Witjes, J.A.; Soares, P.
Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients. Diagnostics 2020, 10, 745.
https://doi.org/10.3390/diagnostics10100745
AMA Style
Sieverink CA, Batista RPM, Prazeres HJM, Vinagre J, Sampaio C, Leão RR, Máximo V, Witjes JA, Soares P.
Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients. Diagnostics. 2020; 10(10):745.
https://doi.org/10.3390/diagnostics10100745
Chicago/Turabian Style
Sieverink, Caroline A., Rui P. M. Batista, Hugo J. M. Prazeres, João Vinagre, Cristina Sampaio, Ricardo R. Leão, Valdemar Máximo, J. Alfred Witjes, and Paula Soares.
2020. "Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients" Diagnostics 10, no. 10: 745.
https://doi.org/10.3390/diagnostics10100745
APA Style
Sieverink, C. A., Batista, R. P. M., Prazeres, H. J. M., Vinagre, J., Sampaio, C., Leão, R. R., Máximo, V., Witjes, J. A., & Soares, P.
(2020). Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients. Diagnostics, 10(10), 745.
https://doi.org/10.3390/diagnostics10100745